Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | sulpiride | 5355 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | sulpiride | 5355 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | sulpiride | 5355 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | minaprine | 4199 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | minaprine | 4199 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | minaprine | 4199 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | minaprine | 4199 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | minaprine | 4199 | drug-path |
| Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | minaprine | 4199 | drug-path |
| Asthma | R-HSA-444620 | map05310 | minaprine | 4199 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | minaprine | 4199 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | minaprine | 4199 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | minaprine | 4199 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | minaprine | 4199 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | minaprine | 4199 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | minaprine | 4199 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | methylbenzethonium chloride | 65576 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | methylbenzethonium chloride | 65576 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | methylbenzethonium chloride | 65576 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | methylbenzethonium chloride | 65576 | drug-path |